Eularis Analyzes Pre-Launch Brand Planning with New Pharmaceutical Industry Report

NEW YORK, LONDON, TOKYO, Nov. 17 (SEND2PRESS NEWSWIRE) — In today’s environment, Pharmaceutical companies find themselves in a bind. Drug launches used to be able to achieve high sales and profits – until recently. Every Pharma company today is hoping to achieve their own immediate winners, the drugs that are successful right from the start and provide years of business-sustaining profit. However, recent studies have shown that seven out of ten drugs launched in the last five years have failed to repay their R&D investment.